Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1

Laboratory Investigation

Volumn 78, Issue 5, 1998, Pages 571-581

  Kimura, Hiroshi ^a   Kasahara, Yasunori ^a   Kurosu, Katsushi ^a   Sugito, Kazutoshi ^a   Takiguchi, Yuichi ^a   Terai, Masaru ^a   Mikata, Atsuo ^a   Natsume, Miyoko ^b   Mukaida, Naofumi ^b   Matsushima, Kouji ^c   Kuriyama, Takayuki ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCROTALINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; HEART WEIGHT; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MACROPHAGE ACTIVATION; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBODIES; CELL MOVEMENT; CHEMOKINE CCL2; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; MACROPHAGES; MALE; MONOCROTALINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031805916     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, Higenbottam T, Oakley C, Wouters E, Aubier M, Simonneau G, and Begaud B (1996). Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 335:609-616.
2. Antoniades HN, Neville-Golden J, Galanopoulos T, Kradin RL, Valente AJ, and Graves DT (1992). Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 89:5371-5375.
3. Arcot SS, Lipke DW, Gillepie MN, and Olson JW (1993). Alterations of growth factor transcript in rat lungs development of monocrotaline-induced pulmonary hypertension. Biochem Pharmacol 46:1086-1091.
4. Baggiolini M, Dewald B, and Moser B (1994). Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol 55:97-179.
5. Better M, Chang CP, Robinson RR, and Horwitz AH (1988). Escherichia coli secretion of an active chimeric antibody fragment. Science 240:1041-1043.
6. Botney MD, Bahadori L, and Gold LI (1994). Vascular remodeling in primary pulmonary hypertension: Potential role for transforming growth factor-beta. Am J Pathol 144:286-295.
7. Brieland JK, Jones ML, Flory CM, Miller GR, Warren JS, Phan SH, and Fantone JC (1993). Expression of monocyte chemoattract protein-I (MCP-1) by rat alveolar macrophages during chronic lung injury. Am J Respir Cell Mol Biol 9:300-305.
8. Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, and Loyd JE (1992). An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327: 70-75.
9. Davies G and Reid L (1970). Growth of the alveoli and pulmonary arteries in childhood. Thorax 25:669-681.
10. Fartoukh M, Emilie D, Simonneau G, and Humbert M (1997). Chemokine MIP-1 α mRNA expression is elevated in lung biopsies of severe primary pulmonary hypertension (abstract). Presented at the Thomas L. Petty Aspen Lung Conference 40th Annual Meeting, June 4-7, 1997, Aspen, Colorado.
11. Fleming I and Busse R (1995). Control and consequences of endothelial nitric oxide formation. Adv Pharmacol 34:187-206.
12. Fulton RM, Huchinson EC, and Morgan JA (1952). Ventricular weight in cardiac hypertrophy. Br Heart J 14:413-420.
13. Furutani Y, Nomura H, Notake M, Oyamada Y, Fukui T, Yamada M, Larsen CG, Oppenheim JJ, and Matsushima K (1989). Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor. Biochem Biophys Res Commun 159:249-255.
14. Gharaee-Kermani M, Denholm EM, and Phan SM (1996). Costimulation of fibroblast collagen and transforming growth factor b1 gene expression by monocytes chemoattractant protein-1 via specific receptors. J Biol Chem 271:17779-17784.
15. Giaid A and Saleh D (1995). Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 333:214-221.
16. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, and Stewart DJ (1993). Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328:1732-1739.
17. Gillespie MN, Olson JW, Hennig B, Cohen DA, McClain CJ, and Goldblum SE (1989). Monokine-induced lung injury in rats: Similarities to monocrotaline-induced pneumotoxicity. Toxicol Appl Pharmacol 98:134-143.
18. Gillespie MN, Simeon EG, Cohen DA, and McClain CJ (1988). Interleukin-1 bioactivity in the lungs of rats with monocrotaline-induced pulmonary hypertension. Proc Soc Exp Biol Med 187:23-32.
19. Hislop A and Reid L (1974). Arterial changes in Crotalaria spectabilis-induced pulmonary hypertension in rats. Br J Exp Pathol 55:153-163.
20. Hislop A and Reid L (1976). New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br J Exp Pathol 57:542-554.
21. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, and Emilie D (1995). Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 151:1628-1631.
22. Jocks T, Zahner G, Freudenberg J, Wolf G, Thaiss F, Helmchen U, and Stahl RA (1996). Prostaglandin E1 reduces the glomerular mRNA expression of monocyte-chemoattractant protein 1 in anti-thymocyte antibody-induced glomerular injury. J Am Soc Nephrol 7:897-905.
23. Jones ML and Warren JS (1992). Monocyte chemoattractant protein 1 in a rat model of pulmonary granulomatosis. Lab Invest 66:498-503.
24. Larsen CG, Zachariae COC, Oppenheim JJ, and Matsushima K (1989). Production of monocyte chemotactic and activating factor (MCAF) by human dermal fibroblasts in response to interleukin 1 or tumor necrosis factor. Biochem Biophys Res Com 160:1403-1408.
25. Liptay MJ, Parks WC, Mecham RP, Roby J, Kaiser LR, Copper JD, and Botney MD (1993). Neointimal macrophage colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J Clin Invest 91:588-594.
26. Luo Y, D'Amore PA, and Dorf ME (1996). Beta-chemokine TCA3 binds to and activates rat vascular smooth muscle cells. J Immunol 157:2143-2148.
27. Matsushima K, Larrsen CG, DuBois GC, and Oppenheim JJ (1989). Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 169:1485-1490.
28. Meyrick B, Gamble W, and Reid L (1980). Development of Crotalaria pulmonary hypertension: Hemodynamic and structural study. Am J Physiol 239:H692-H702.
29. Mitani Y, Maruyama K, and Sakurai M (1997). Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 96:689-697.
30. Miyata A, Sakuma F, Yoshimura A, Ishikawa H, Nishimaki T, and Kasukawa R (1995a). Pulmonary hypertension in rats: 1 - Role of bromodeoxyuridine-positive mononuclear cells and alveolar macrophages. Int Arch Allergy Immunol 108: 281-286.
31. Miyata A, Sakuma F, Yoshimura A, Ishikawa H, Nishimaki T, and Kasukawa R (1995b). Pulmonary hypertension in rats: 2 - Role of interleukin-6. Int Arch Allergy Immunol 108:287-291.
32. Morse JH, Jones AC, Barst RJ, Hodge SE, Wilhelmsen KC, and Nygaard TG (1997). Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-q32. Circulation 95:2603-2606.
33. Nakano Y, Kasahara T, Mukaida N, Ko YC, Nakano M, and Matsushima K (1994). Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor. Infect Immunol 62:377-383.
34. Nakashima E, Mukaida N, Kubota Y, Kuno K, Yasumoto K, Ichimura F, Nakanishi I, Miyasaka M, and Matsushima K (1995). Human MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma line in vivo. Pharm Res 12:1598-1604.
35. Nathan CF (1987). Secretory products of macrophages. J Clin Invest 79:319-326.
36. Nichols WC, Koller DL, Slovis B, Foroud T, Terry VH, Arnold ND, Siemieniak DR, Wheeler L, Phillips JA III, Newman JH, Conneally PM, Ginsburg D, and Loyd JE (1997). Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat Genet 15:277-280.
37. Okawa-Takatsuji M, Aotsuka S, Uwatoko S, Sumiya M, and Yokohari R (1994). Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: Implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD). Clin Exp Immunol 98:427-433.
38. Olson JW, Altiere RJ, and Gillespie MN (1984). Prolonged activation of rat lung ornithine decarboxylase in monocrotaline induced pulmonary hypertension. Biochem Pharmacol 33:3633-3637.
39. Ono S and Voelkel NF (1991). PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension. J Appl Physiol 71:2483-2492.
40. Porreca E, Di-Febbo C, Realle M, Castellani ML, Baccante G, Barbacane R, Conti P, Cuccurulo F, and Poggi A (1997). Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. J Vasc Res 34:58-65.
41. Postlethwaite AE and Seyer JM (1995). Identification of a chemotactic epitope in human transforming growth factor-b1 spanning amino acid residues 368-374. J Cell Physiol 164: 587-592.
42. Rich S and Brundage BH (1989). Pulmonary hypertension: A cellular basis for understanding the pathophysiology and treatment. J Am Coll Cardiol 14:545-550.
43. Rollins BJ (1996). Monocyte chemoattractant protein 1: A potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 2:198-204.
44. Rollins BJ, Stier P, Ernst TE, and Wong CG (1989). The human homologue of the JE gene encodes a monocyte secretory protein. Mol Cell Biol 9:4687-4695.
45. Rosenberg HC and Rabinovitch M (1988). Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. Am J Physiol 255:H1484-H1491.
46. Rubin LJ (1997). Primary pulmonary hypertension. N Engl J Med 336:111-117.
47. Rubin LJ, Groves BM, Reeves JT, Frosolono M, Handel F, and Cato AE (1982). Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension. Circulation 66:334-338.
48. Sakanashi Y, Takeya M, Yoshimura T, Feng L, Morioka T, and Takahashi K (1994). Kinetics of macrophage subpopulations and expression of monocyte chemoattractant protein-1 (MCP-1) in bleomycin-induced lung injury of rats studied by a novel monoclonal antibody against rat MCP-1. J Leukoc Biol 56:741-750.
49. Schaiberger PH, Kennedy TC, Miller FC, Gal J, and Petty TL (1993). Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine. Chest 104:614-616.
50. Shellito J, Esparza C, and Armstrong C (1987). Maintenance of normal alveolar macrophage populations: The roles of monocyte influx and proliferation in situ. Am Rev Respir Dis 135:78-82.
51. Speich R, Jenni R, Opravil M, Pfab M, and Russi EW (1991). Primary pulmonary hypertension in HIV infection. Chest 100: 1268-1271.
52. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan SY, Roczniak S, and Shnafelt AB (1995). The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270:27348-27357.
53. Sugita T, Hyers TM, Dauber IM, Wagner WW, McMurtry IF, and Reeves JT (1983). Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats. J Appl Physiol 54:371-374.
54. Sugiyama Y, Kasahara T, Mukaida N, Matsushima K, and Kitamura S (1995). Chemokines in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis. Eur Respir J 8:1084-1090.
55. Tanaka Y, Bernstein ML, Mecham RP, Patterson GA, Cooper JD, and Botney MD (1996). State specific responses to monocrotaline-induced vascular injury: Evidence for two distinct mechanisms of remodeling. Am J Respir Cell Mol Biol 15:391-397.
56. Todorovich-Hunter L, Johnson DJ, Ranger P, Keeley FW, and Rabinovitch M (1988). Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline: A biochemical and ultrastructural study. Lab Invest 58:184-195.
57. Tsao PS, Wang B, Buitrago R, Shyy J, and Cooke JP (1997). Nitric oxide regulates monocyte chemotactic protein-1. Circulation 96:934-940.
58. Tuder RM, Groves B, Badesch DB, and Voelkel NF (1994). Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 144:275-285.
59. van Oud Alblas AB, Mattie H, and van Furth R (1983). A quantitative evaluation of pulmonary macrophage kinetics. Cell Tissue Kinet 16:211-219.
60. Voelkel NF, Tuder RM, Bridges J, and Arend WP (1994). Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am J Respir Cell Mol Biol 11:664-675.
61. Wada T, Yokoyama H, Furuichi K, Kobayashi KI, Harada K, Naruto M, Su SB, Akiyama M, Mukaida N, and Matsushima K (1996). Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP- 1). FASEB J 10:1418-1425.
62. Ye CL and Rabinovitch M (1991). Inhibition of elastolysis by SC-37698 reduces development and progression of monocrotaline pulmonary hypertension. Am J Physiol 261:H1255-H1267.
63. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum J, and Steinberg D (1991). Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88:10143-10147.
64. Yoshimura T, Robinson EA, Tanaka S, Appela E, and Leonard EJ (1989). Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J Immunol 142:1956-1962.
65. Zeiher AM, Fisslthaler B, Schray-Utz B, and Busse R (1995). Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 76:980-986.
66. Zhang K, Kermani MG, Jones ML, Warren JS, and Phan SH (1994). Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J Immunol 153:4733-4741.